9.1 C
New York
Sunday, May 9, 2021

Siberian doctors say they saved Kremlin critic Navalny’s life

Must read

IDFC First Bank Q4 Results: Profit jumps 78% to Rs 128 crore

Total income during the fourth quarter rose to Rs 4,834 crore as against Rs 4,576 crore during the same period of FY20, IDFC First...

Reliance Capital Q4 Results: Loss narrows to Rs 1,649 crore

On a standalone basis, Reliance Capital posted a loss of Rs 3,865 crore as against Rs 2,501 crore at the end of same quarter...
imageWorld8 minutes ago (Aug 24, 2020 04:35AM ET)

(C) Reuters. FILE PHOTO: Russian opposition politician Alexei Navalny takes part in a rally to mark the 5th anniversary of opposition politician Boris Nemtsov’s murder and to protest against proposed amendments to the country’s constitution, in Moscow

MOSCOW (Reuters) – Doctors at the Siberian hospital that first treated Russian opposition politician Alexei Navalny said on Monday that they had saved his life but that they had not found traces of poison in his system.

Navalny, a long-time opponent of President Vladimir Putin, fell gravely ill on Thursday after what his allies believe was a poisoning and was airlifted to Germany for treatment on Saturday.

“We saved his life with great effort and work,” head doctor Alexander Murakhovsky told reporters at a news conference in the Siberian city of Omsk.

“If we had found some kind of poison that was somehow confirmed then it would have been a lot easier for us. It would have been a clear diagnosis, a clear condition and a well-known course of treatment,” said Anatoly Kalinichenko, a senior doctor at the hospital.

The Russian doctors did not say on Monday what specifically they had done to save Navalny’s life or what they had treated him for. Last week they said they had diagnosed him with metabolic disease possibly brought on by low blood sugar.

The doctors denied they had come under pressure from authorities while treating Navalny.

Navalny’s allies had accused doctors of holding up Navalny’s evacuation to Germany. The doctors initially said Navalny was not in a fit state to be transported there for treatment.

Jaka Bizilj, founder of Germany’s Cinema for Peace Foundation, told mass tabloid Bild over the weekend that Navalny, who is being treated in a German hospital, would survive.

He said: “Navalny will survive poison attack, but be incapacitated for months as a politician.”

But Kira Yarmysh, Navalny’s spokeswoman, said that there were still no new details about the politician’s condition and that only she or the doctors treating him would be able to provide reliable information.

Siberian doctors say they saved Kremlin critic Navalny’s life

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

- Advertisement -

Latest article

IDFC First Bank Q4 Results: Profit jumps 78% to Rs 128 crore

Total income during the fourth quarter rose to Rs 4,834 crore as against Rs 4,576 crore during the same period of FY20, IDFC First...

Reliance Capital Q4 Results: Loss narrows to Rs 1,649 crore

On a standalone basis, Reliance Capital posted a loss of Rs 3,865 crore as against Rs 2,501 crore at the end of same quarter...

HDFC to off-load 0.62% stake in general insurance subsidiary

HDFC has entered into a share purchase agreement for sale of 44,12,000 equity shares of Rs 10 each, representing 0.62 per cent of the...